Complete financial analysis of Delic Holdings Corp. (DELCF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Delic Holdings Corp., a leading company in the Internet Content & Information industry within the Communication Services sector.
- Prospex Energy PLC (PXEN.L) Income Statement Analysis – Financial Results
- TTET Union Corporation (1232.TW) Income Statement Analysis – Financial Results
- Clevo Co. (2362.TW) Income Statement Analysis – Financial Results
- TPG Pace Beneficial Finance Corp. (TPGY-UN) Income Statement Analysis – Financial Results
- Investeringsforeningen Investin – I&T Nordiske Aktier Large Cap (INIITNAKTLC.CO) Income Statement Analysis – Financial Results
Delic Holdings Corp. (DELCF)
Industry: Internet Content & Information
Sector: Communication Services
Website: https://deliccorp.com
About Delic Holdings Corp.
Delic Holdings Corp. provides various medicines and treatments in the United States and Canada. It operates The Delic, a creative platform that creates and hosts public discourse about psychedelic culture; Meet Delic, which organizes event to promote topics, such as safety and harm reduction, Hollywood, mental health and psychedelics, the power of integration, human performance, medicine, and other topics; Reality Sandwich, a public online education platform with approximately 10,000 pieces of content, including psychedelic guides, news, and culture; and Delic Radio, a podcast that discusses topics related to the psychedelic space with experts comprising discussions relating to news, science, culture, medicine, current affairs, and policy. The company also focuses on developing intellectual property through research and development for cannabis and psychedelics. In addition, it owns and operates two ketamine infusion treatment clinics; and thirteen ketamine infusion treatment clinics. The company is headquartered in Vancouver, Canada.
| Metric | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|
| Revenue | 1.98M | 0.00 | 4.49M | 0.00 |
| Cost of Revenue | 2.02M | 74.81K | 3.28M | 0.00 |
| Gross Profit | -41.00K | -74.81K | 1.21M | 0.00 |
| Gross Profit Ratio | -2.07% | 0.00% | 26.97% | 0.00% |
| Research & Development | 214.00K | 46.11K | 0.00 | 0.00 |
| General & Administrative | 5.19M | 732.10K | 137.24K | 41.11K |
| Selling & Marketing | 1.94M | 232.62K | 144.29K | 0.00 |
| SG&A | 7.13M | 964.73K | 137.24K | 41.11K |
| Other Expenses | 0.00 | 39.96K | 0.00 | 0.00 |
| Operating Expenses | 1.57M | 1.01M | 137.24K | 41.11K |
| Cost & Expenses | 9.20M | 1.01M | 137.24K | 41.11K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 25.26 | 18.35 |
| Depreciation & Amortization | 131.38K | 16.71K | 13.13K | 161.14K |
| EBITDA | -5.75M | -489.47K | 467.56K | -41.11K |
| EBITDA Ratio | -290.32% | 0.00% | -3.06% | 0.00% |
| Operating Income | -7.22M | -383.85K | -137.24K | -41.11K |
| Operating Income Ratio | -364.62% | 0.00% | -3.06% | 0.00% |
| Total Other Income/Expenses | -2.27M | -423.58K | -377.98K | -18.35 |
| Income Before Tax | -9.49M | -1.60M | -137.26K | -41.13K |
| Income Before Tax Ratio | -479.19% | 0.00% | -3.06% | 0.00% |
| Income Tax Expense | -628.00K | 420.69K | -0.77 | -161.14K |
| Net Income | -8.86M | -1.60M | -137.26K | -41.13K |
| Net Income Ratio | -447.48% | 0.00% | -3.06% | 0.00% |
| EPS | -0.16 | -0.18 | 0.00 | 0.00 |
| EPS Diluted | -0.16 | -0.18 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 54.75M | 9.11M | 37.67M | 38.12M |
| Weighted Avg Shares Out (Dil) | 54.75M | 9.11M | 38.12M | 38.12M |
Delic Holdings Inc. Announces Meet DELIC, the Premiere Psychedelic and Wellness Edutainment Event and Expo for Newcomers and Veteran Psychonauts, Announces Initial Speaker Lineup
Leading Psychedelic Wellness Company Delic Signs Definitive Agreement to Acquire Ketamine Infusion Centers Llc, Bringing Physical Retail Chain to Delic Portfolio
Delic's Acquisition Target, Complex Biotech Discovery Ventures Ltd., Announces Closing of Non-Brokered Private Placement
Delic Holdings Inc. Confirms No Material Undisclosed Information and Comments on Recent Promotional Activities
Delic's Acquisition Target, Complex Biotech Discovery Ventures Ltd., Receives First Research Orders Through Online Payment Platform
Delic Holdings, a Psychedelic Wellness-focused Company, Announces Appointment of John Coleman as Vice President of Business Development
Source: https://incomestatements.info
Category: Stock Reports